Board Meeting Details

The Board of Directors meeting was held on August 11, 2026, at the Registered Office in Kolkata, commencing at 12:30 PM and concluding at 2:15 PM.

Key Board Decisions

1. Approved Un-Audited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2026

2. Reviewed and took on record the Monitoring Agency Report for Rights Issue proceeds utilization for Q1 FY27

3. Noted and approved Statement of Deviation(s) or Variation(s) under Regulation 32 - no deviations found in utilization of public/rights issue proceeds

4. Approved comprehensive Corporate Social Responsibility (CSR) Policy and CSR Annual Action Plan for FY 2026-27

Financial Results - Standalone (₹ in Lakhs)

Quarter Ended June 30, 2026

  • Total Income: ₹726.97
  • Total Expenses: ₹558.34
  • Profit before tax: ₹168.63
  • Tax Expense: ₹41.18 (Deferred Tax)
  • Net Profit after tax: ₹127.45
  • Other Comprehensive Income: ₹632.37 (Equity instruments through OCI)
  • Total Comprehensive Income: ₹759.82
  • Paid-up Equity Share Capital: ₹1,073.55 (Face Value ₹10 per share)
  • Basic & Diluted EPS: ₹1.22

Segment Revenue (Standalone)

  • Capital Market Operations: ₹282.49
  • Investment Banking Operations: ₹20.22
  • Unallocated: ₹424.26

Financial Results - Consolidated (₹ in Lakhs)

Quarter Ended June 30, 2026

  • Total Income: ₹727.66
  • Total Expenses: ₹561.99
  • Profit before tax: ₹165.67
  • Tax Expense: ₹41.16 (Deferred Tax)
  • Net Profit after tax: ₹124.51
  • Other Comprehensive Income: ₹632.38 (Equity instruments through OCI)
  • Total Comprehensive Income: ₹756.89
  • Paid-up Equity Share Capital: ₹1,073.55
  • Basic & Diluted EPS: ₹1.19

Subsidiaries Included in Consolidation

1. Nexome Capital Services Limited (India)

2. Nexome Wealth Management Limited (India)

  • Subsidiaries contributed total revenue of ₹0.69 lakhs and total net loss of ₹2.95 lakhs for the quarter

Capital Structure Events

Rights Issue Completion

  • Completed rights issue of 29,38,500 fully paid-up equity shares of ₹10 each
  • Issue price: ₹75 per share (including premium of ₹65 per share)
  • Total proceeds: ₹2,203.875 lakhs
  • Shares allotted on March 24, 2026
  • Funds fully received with no deviations in utilization

Warrant Conversion

  • Preferential allotment of 19,20,000 Equity Convertible Warrants on October 25, 2024
  • Conversion terms: Each warrant convertible into equity share of ₹10 at premium of ₹54 per share
  • 25% consideration (₹307.20 lakhs) received as of March 31, 2025
  • Converted 19,20,000 warrants into 19,20,000 equity shares on April 20, 2026
  • Received balance 75% consideration of ₹921.60 lakhs
  • New shares rank pari-passu with existing equity shares

Loan Portfolio Provisioning

  • Company maintains ad hoc provision at 6% on outstanding loan portfolio
  • Total provision: ₹169.33 lakhs as of June 30, 2026
  • Provision reversal during quarter: ₹24.92 lakhs (credited to Profit and Loss)

Auditor Review

  • Statutory Auditors: S K Agrawal and Co Chartered Accountants LLP
  • Review conducted under SRE 2410
  • Unmodified opinion on both standalone and consolidated results
  • Emphasis of Matter notes on rights issue, warrant conversion, and loan provision